| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/29/2005 | US20050211572 monitoring analyte glucose concentration in a biological fluid by applying a potential to the electrode, comparison with known concentrations of the analyte in medium |
| 09/29/2005 | US20050211559 Use of microfluidic systems in the electrochemical detection of target analytes |
| 09/29/2005 | DE19781288B4 Opake Reaktionsmatrix zur Analyse von Vollblut Opaque response matrix for the analysis of whole blood |
| 09/29/2005 | DE10346363B4 Verfahren zur Methylierungsanalyse von DNA A method for methylation analysis of DNA |
| 09/29/2005 | DE102005015000A1 Verfahren und System zur Analyse von arraybasierten Komparativhybridisierungsdaten A method and system for the analysis of array-based Komparativhybridisierungsdaten |
| 09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 09/29/2005 | DE102004012481A1 Using uridine monophosphate synthase as target for identifying herbicides and plant growth regulators, also the identified compounds and transgenic plants resistant to them |
| 09/29/2005 | DE102004011822A1 Qualitätssicherungssystem zum Nachweis von Mikroorganismen Quality assurance system for the detection of microorganisms |
| 09/29/2005 | DE102004009952A1 Verfahren zur Erkennung von Sepsis A method for the detection of sepsis |
| 09/29/2005 | CA2560292A1 Inhibitors of gob-4 protein as asthma therapeutics |
| 09/29/2005 | CA2560242A1 Human obesity susceptibility genes encoding peptide hormones and uses thereof |
| 09/29/2005 | CA2559955A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/29/2005 | CA2559936A1 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 09/29/2005 | CA2559840A1 Prostatic acid phosphatase antigens |
| 09/29/2005 | CA2559768A1 Method of stirring solution |
| 09/29/2005 | CA2559544A1 C20orf23 as modifier of the igfr pathway and methods of use |
| 09/29/2005 | CA2559543A1 Pdes as modifiers of the igfr pathway and methods of use |
| 09/29/2005 | CA2559453A1 Methods and apparatus for integrated cell handling and measurements |
| 09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 09/29/2005 | CA2559209A1 Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| 09/29/2005 | CA2558749A1 Polynucleotide synthesis |
| 09/29/2005 | CA2558649A1 Neoplasia diagnostic compositions and methods of use |
| 09/29/2005 | CA2558559A1 Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products |
| 09/29/2005 | CA2558553A1 Assay for detecting and identifying micro-organisms |
| 09/29/2005 | CA2558269A1 Sequence capable of accelerating gene expression at moderately low temperature |
| 09/29/2005 | CA2557476A1 Nitrile hydratases from metagenome libraries |
| 09/29/2005 | CA2502070A1 Polymer composite comprising hydrophilic, photo-cured membrane |
| 09/28/2005 | EP1580681A2 Method for processing missing values in measured data |
| 09/28/2005 | EP1580596A2 Structure formed with template having nanoscale features |
| 09/28/2005 | EP1580559A1 Methods for reducing the variance between analyte concentrations taken from complex sample mixtures |
| 09/28/2005 | EP1580554A1 Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polynucleotide |
| 09/28/2005 | EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma |
| 09/28/2005 | EP1580281A2 Method for microbial antibiotic resistance detection |
| 09/28/2005 | EP1580280A1 Method for detection of base sequence of interest |
| 09/28/2005 | EP1580279A1 Method of measuring lipid in specific lipoprotein |
| 09/28/2005 | EP1580269A1 Method of detecting gene mutation |
| 09/28/2005 | EP1580266A1 Screening method |
| 09/28/2005 | EP1580265A1 Nucleic acids isolated from neuroblastoma at stage 4s |
| 09/28/2005 | EP1580196A1 Monitor protein for measuring processing of protein |
| 09/28/2005 | EP1579220A2 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer |
| 09/28/2005 | EP1579216A2 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 09/28/2005 | EP1579215A2 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates |
| 09/28/2005 | EP1579210A1 Colorimetric sensors constructed of diacetylene materials |
| 09/28/2005 | EP1579186A2 Identification of kinase inhibitors |
| 09/28/2005 | EP1579015A2 Method for pcr cleanup and oligonucleotide removal |
| 09/28/2005 | EP1579014A2 Method for the detection of legionella-type bacteria |
| 09/28/2005 | EP1579013A2 Method for profiling and identifying persons by using data samples |
| 09/28/2005 | EP1579012A2 Monitoring high-risk environments |
| 09/28/2005 | EP1579010A2 Susceptibility gene for myocardial infarction; methods of treatment |
| 09/28/2005 | EP1579009A1 Methods and compositions for sequencing nucleic acid molecules |
| 09/28/2005 | EP1579008A1 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles |
| 09/28/2005 | EP1579007A2 Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| 09/28/2005 | EP1579006A2 Modulation of jagged 1 expression |
| 09/28/2005 | EP1579005A1 Methods and compositions for analysis of regulatory sequences |
| 09/28/2005 | EP1579004A2 Screening methods for identification of efficient pre-trans-splicing molecules |
| 09/28/2005 | EP1579003A2 Methods and compositions relating to drug-induced arrhythmia |
| 09/28/2005 | EP1579002A2 Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection |
| 09/28/2005 | EP1579000A1 Magnetism based nucleic acid amplification |
| 09/28/2005 | EP1578999A2 Molecules and methods using same for measuring non-transferrin bound iron |
| 09/28/2005 | EP1578998A2 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use |
| 09/28/2005 | EP1578996A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578995A2 Method and system for cell and/or nucleic acid molecules isolation |
| 09/28/2005 | EP1578994A2 Methods for identifying dna copy number changes |
| 09/28/2005 | EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
| 09/28/2005 | EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 09/28/2005 | EP1578989A2 Novel nucleic acids and secreted polypeptides |
| 09/28/2005 | EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 09/28/2005 | EP1578986A1 Process for preparation of enzyme electrode |
| 09/28/2005 | EP1578985A1 Lactate biosensing strip |
| 09/28/2005 | EP1578984A1 Method for preparing lactate biosensing strip |
| 09/28/2005 | EP1578982A2 Nucleic acid amplification methods |
| 09/28/2005 | EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof |
| 09/28/2005 | EP1578980A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 09/28/2005 | EP1578960A1 Magnetism based rapid cell separation |
| 09/28/2005 | EP1578952A2 Direct snp detection with unamplified dna |
| 09/28/2005 | EP1578951A2 Dna polymerases with reduced base analog detection activity |
| 09/28/2005 | EP1578948A2 Flj10607 as modifier of the axin pathway and methods of use |
| 09/28/2005 | EP1578945A2 Cct6s as modifiers of the rb pathway and methods of use |
| 09/28/2005 | EP1578944A2 Compositions and methods for inferring ancestry |
| 09/28/2005 | EP1578941A2 Csnks as modifiers of the rac pathway and methods of use |
| 09/28/2005 | EP1578940A2 Methods and compositions for diagnosing dysplasia |
| 09/28/2005 | EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 09/28/2005 | EP1578933A2 Compositions and methods for si-rna inhibition of angiogenesis |
| 09/28/2005 | EP1578932A2 Synthetic tag genes |
| 09/28/2005 | EP1578930A2 Cngh0004 polypeptides, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578928A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/28/2005 | EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 09/28/2005 | EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578918A2 Atherosclerotic phenotype determinative genes and methods for using the same |
| 09/28/2005 | EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578913A2 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 09/28/2005 | EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578910A2 Nitrilases |
| 09/28/2005 | EP1578908A2 Human schizophrenia gene |
| 09/28/2005 | EP1578907A2 Secreted protein, ztnf9 |
| 09/28/2005 | EP1578906A2 Afap sequences, polypeptides, antibodies and methods |